Skip to main content
Fig. 4 | Journal of Venomous Animals and Toxins including Tropical Diseases

Fig. 4

From: Combination of heterologous fibrin sealant and bioengineered human embryonic stem cells to improve regeneration following autogenous sciatic nerve grafting repair

Fig. 4

Anti-ChAT immunostaining of (a) the control nerves and (b to g) all groups, 60 days after surgery. h Quantification of the integrated density of pixels in the experimental groups in relation to control group (%). Statistically, there is no significant difference among experimental groups. Scale bar: 50 μm. N: neurorrhaphy, F: heterologous fibrin sealant, D: doxycycline, T: transgenic hESCs

Back to article page
\